Lobbying · Company
Novartis
Meetings with ministers
17
In the last 12 months
4
Different ministers
12
Lobbying firms used
1
Meetings with ministers
| Date | Minister | Purpose, as published |
|---|---|---|
| 11 May 2026 | Zubir AhmedDHSC | To discuss the US-UK pharmaceutical arrangement |
| 10 February 2026 | Dr Zubir AhmedDHSC | To discuss life sciences priorities |
| 20 January 2026 | Jason StockwoodDBT | To discuss the UK life sciences investment environment |
| 2 December 2025 | Dr Zubir AhmedDHSC | To discuss the US-UK deal on life sciences trade and pricing |
| 19 June 2025 | Gillian MerronDHSC | To discuss the UK's Life Sciences sector |
| 2 June 2025 | Patrick VallanceDSIT | To discuss the pharmaceutical landscape in the UK |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Sir Keir StarmerPrime Minister | Biopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy |
| 2 April 2025 | Peter KyleDSIT | Roundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data |
| 2 April 2025 | Jonathan ReynoldsDBT | To discuss the policy environment for the life sciences sector in the UK |
| 2 April 2025 | Poppy GustafssonDBT | To discuss the UK life sciences commerical environment and investment in this sector |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Patrick VallanceDSIT | To discuss the life sciences industry in the UK |
| 2 April 2025 | Patrick VallanceDSIT | Biopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable |
| 22 January 2025 | Sarah JonesDBT | Meeting at Davos to discuss business and investment in the UK |
| 12 September 2024 | Karin SmythDHSC | To discuss ongoing partnership regarding Inclisiran |
Consultant lobbying firms
- Incisive Health LtdApril to June 2025
